| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.21 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |